Abitesartan: Difference between revisions
Appearance
Content deleted Content added
Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB) |
+ cite |
||
Line 49: | Line 49: | ||
}} |
}} |
||
'''Abitesartan''' ([[International Nonproprietary Name|INN]]) is an [[Angiotensin II receptor antagonist]]. |
'''Abitesartan''' ([[International Nonproprietary Name|INN]]) is an [[Angiotensin II receptor antagonist]].<ref>{{cite journal | vauthors = Ladhari A, La Mura G, Di Marino C, Di Fabio G, Zarrelli A | title = Sartans: What they are for, how they degrade, where they are found and how they transform. | journal = Sustainable Chemistry and Pharmacy | date = May 2021 | volume = 20 | page = 100409 | doi = 10.1016/j.scp.2021.100409 }}</ref> |
||
==References== |
==References== |
||
{{Reflist |
{{Reflist}} |
||
{{Angiotensin receptor modulators}} |
{{Angiotensin receptor modulators}} |
Revision as of 06:45, 29 August 2021
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H31N5O3 |
Molar mass | 461.566 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Abitesartan (INN) is an Angiotensin II receptor antagonist.[1]
References
- ^ Ladhari A, La Mura G, Di Marino C, Di Fabio G, Zarrelli A (May 2021). "Sartans: What they are for, how they degrade, where they are found and how they transform". Sustainable Chemistry and Pharmacy. 20: 100409. doi:10.1016/j.scp.2021.100409.